Evaluation of Explanted CorMatrix Tyke Extracardiac Patches in Infants With Congenital Heart Disease

Ann Thorac Surg. 2021 Nov;112(5):1518-1522. doi: 10.1016/j.athoracsur.2020.06.151. Epub 2020 Oct 22.


Background: Animal data demonstrate that intracardiac patches of decellularized porcine small intestine submucosa (CorMatrix; CorMatrix Cardiovascular, Atlanta, GA) become repopulated with native cells, suggesting the possibility of a substrate for regenerative tissue in humans. Although human studies have not demonstrated this regenerative property with intracardiac patches, it is possible that other environments may better promote native cell repopulation. We report a prospective series of explanted CorMatrix extracardiac patches placed in infants with congenital heart disease.

Methods: CorMatrix Tyke patches were used in pulmonary artery patch closure during the Norwood procedure. The patch material was explanted as part of the hemi-Fontan procedure. Specimens were analyzed with the use of hematoxylin and eosin, Movat pentachrome, and trichrome stains.

Results: Of the 11 implantations, 9 specimens were explanted. One patient did not survive to hemi-Fontan procedure. One patient's patch was removed, but not analyzed. Acellular material, chronic inflammation, fibrosis, and foreign body giant cell reaction was seen in all explanted patches. No explanted CorMatrix Tyke material demonstrated evidence of ingrowth of native endothelial tissue at a median of 4.9 months in vivo.

Conclusions: CorMatrix Tyke patch material, placed as a pulmonary artery patch in an extracardiac position, remained pliable and mostly free of calcification. However, these patches did not show evidence of native endothelial tissue at a median of 4.9 months in vivo.

MeSH terms

  • Cardiac Surgical Procedures / methods
  • Heart Defects, Congenital / surgery*
  • Humans
  • Infant, Newborn
  • Prospective Studies
  • Prostheses and Implants*
  • Pulmonary Artery / surgery*